Cambridge Investment Research Advisors
EOLS icon

Cambridge Investment Research Advisors’s Evolus EOLS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-14,635
Closed -$78K – 2547
2020
Q2 		$78K Buy
14,635
+2,413
+20% +$11.1K ﹤0.01% 2343
2020
Q1 		$51K Buy
+12,222
New +$104K ﹤0.01% 2181

Other funds holding EOLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cambridge Investment Research Advisors's EOLS Position: Q3 2020 in Review

Cambridge Investment Research Advisors sold out of Evolus (EOLS) in Q3 2020, closing a stake of 14,635 shares — an estimated $78K sold.

Cambridge Investment Research Advisors first reported a position in EOLS in Q1 2020 and held it in 2 quarters. The position peaked at $78K in Q2 2020. 87 funds tracked by Wall St. Rank hold EOLS as of Q3 2020.

  • Cambridge Investment Research Advisors reported no remaining Evolus position as of Q3 2020 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 14,635 Evolus shares in Q3 2020, an estimated $78K.
  • Cambridge Investment Research Advisors first reported a position in Evolus in Q1 2020 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's Evolus position peaked at $78K in Q2 2020.
  • 87 funds tracked by Wall St. Rank held Evolus as of Q3 2020.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.